COMPARISON OF HYPERFRACTIONATION AND CONVENTIONAL METHOD OF RADIOTHERAPY IN HEAD AND NECK CANCERS.

Nandakumar A, Rath GK, Kataki AC, et al. Survival in head and neck cancers. Results of a multi-institutional study. Asian Pac J Cancer Prev 2016;17(4):1745-54.               

Saunders MI. Head and neck cancers: altered fractionation schedules. The Oncologist 1999;4(1):11-6.                      

Alam MS, Perween R, Siddiqui SA. Comparison of two different radiation fractionation schedules with concurrent chemotherapy in head and neck malignancy. Indian J Cancer 2016;53(2):265-9.               

Ang KK. Altered fractionation trials in head and neck cancer. Semin Radiat Oncol 1998;8(4):230-6.          

Ang KK. Altered fractionation in the management of head and neck cancer. Int J Radiat Biol 1998;73(4):395-9.           

Baujat B, Bourhis J, Blanchard P, et al. Hyperfractionated or accelerated radiotherapy for head and neck cancer. Conchrane Database of Systemic Review 2010;(12): CD002026.              

Overgaard J, Mohanti BK, Begum N, et al. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of head and neck(IAEA-ACC Study): a randomised, multicentre trial. Lancet Oncol 2010;11(6):553-60.             

Tirkes T, Hollar MA, Tann M, et al. Response criteria in oncologic imaging: review of traditional and new criteria. Radographics 2013;33(5):1323-41.         

Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherpy. Acta Oncol 1988;27(2):131-46. 

Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48(1):7-16.               

Horiot JC, Bontemps P, van den Bogaert W, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial. Radiother Oncol 1997;44(2):111-21.              

Overgaard J, Hielm-Hansen M, Johansen LV, et al. Comparison of conventional and split course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol 1988;27(2):147-52.              

Wilson GD, Mcnally NJ, Dische S, et al. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 1988;58(4):423-31.   

Dobrowsky W, Dobrowsky E, Naude J, et al. Conventional vs accelerated fractionation in head and neck cancer. British Journal of Cancer Supplement 1996;27:S279-81.  

Denekamp J, Dasu A, Waites A, et al. Hyperfractionation as an effective way of overcoming radioresistance. Int J Radiat Oncol Biol Phys 1998;42(4):705-9.             

Mishra H, Mishra R, Shahi UP, et al. A randomised prospective study of concurrent chemo-radiotherapy vs accelerated hyperfractionation in advanced cancer of head and neck. J Clin Diagn Res 2016;10(10):XC15-XC18.